What is ulipristal acetate 5 mg used for?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ulipristal Acetate 5mg: Indication and Use

Note: The question asks about ulipristal 5mg, but the standard emergency contraception dose is 30mg, not 5mg. There is also a 5mg formulation of ulipristal acetate that exists for a completely different indication—treatment of uterine fibroids (marketed as Esmya in Europe). However, the evidence provided focuses exclusively on the 30mg emergency contraception formulation. I will address the emergency contraception use, as this is what the available evidence supports.

Primary Indication: Emergency Contraception

Ulipristal acetate 30mg (not 5mg) is used as emergency contraception to prevent pregnancy when taken within 5 days (120 hours) after unprotected sexual intercourse or contraceptive failure. 1, 2

Mechanism of Action

  • Ulipristal acetate is a selective progesterone receptor modulator that works primarily by inhibiting or delaying ovulation 2, 3
  • It can delay the onset of luteinizing hormone (LH) surge or postpone LH peak even if LH surge has already started 3
  • It may also have a direct inhibitory effect on follicular rupture when administered just before ovulation 3

Timing and Effectiveness Window

  • Effective throughout the entire 120-hour (5-day) window after unprotected intercourse, unlike levonorgestrel which loses effectiveness after 72 hours 2
  • Should be taken as soon as possible within this 5-day period for maximum effectiveness 2
  • Maintains sustained efficacy even when taken 72-120 hours after intercourse, whereas levonorgestrel shows significantly reduced effectiveness in this later window 1, 4

Comparative Effectiveness

  • More effective than levonorgestrel (Plan B), particularly in the 72-120 hour window after intercourse 1, 4
  • Meta-analysis shows ulipristal acetate has a pregnancy risk 42% lower than levonorgestrel up to 72 hours and 65% lower in the first 24 hours 5, 6
  • May be more effective than levonorgestrel in women who are overweight or obese 1, 2
  • Levonorgestrel loses effectiveness in women weighing more than 165 pounds and is ineffective in women weighing more than 176 pounds 1
  • Among emergency contraception options, copper IUDs are most effective, followed by ulipristal acetate, then levonorgestrel 2

Administration and Follow-up

  • Single oral dose of 30mg (again, not 5mg as asked in the question) 3, 4
  • After taking ulipristal acetate, women can start regular contraception immediately but must use barrier contraception or abstain for 14 days or until next menstrual period 2
  • A pregnancy test is recommended if withdrawal bleeding does not occur within 3 weeks 2

Safety Profile

  • Generally well tolerated with similar side effects to levonorgestrel 3, 6
  • Most common adverse event is headache (19.3% of users) 4
  • Typically delays onset of menses by 2-3 days 3
  • Pregnancy category X: unlike levonorgestrel, a pregnancy test may be considered before prescribing 1

Drug Interactions

  • Predominantly metabolized by CYP3A4, so interactions with antiretroviral agents (particularly efavirenz) can be expected 1
  • Limited evidence suggests levonorgestrel levels are significantly reduced with efavirenz use 1

Important Clinical Caveat

The 5mg formulation mentioned in your question is NOT the emergency contraception dose. The emergency contraception formulation is 30mg (marketed as ella® in the US or ellaOne® in Europe). If you are asking about the 5mg daily formulation, this is used for treatment of uterine fibroids, which is an entirely different indication not covered by the provided evidence.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.